{"title":"Commentary on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic neoplasms","authors":"Robert Peter Gale, Christophe Badie","doi":"10.1038/s41375-025-02544-3","DOIUrl":null,"url":null,"abstract":"<p><i>Post hoc ergo propter hoc?</i></p><p>We write, somewhat belatedly, to comment on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms [1]. This is a landmark article and global reference on this topic. However, might we take issue on the small but important section heading: <i>Secondary myeloid neoplasms</i> (p. 1710) and especially the sub-section: <i>Myeloid neoplasms post cytotoxic therapy: Introduction of more precise terminology and novel associations with new cytotoxic drug classes</i>. The text goes on to use the term: <i>myeloid neoplasms post cytotoxic therapy</i> (MN-pCT).</p>","PeriodicalId":18109,"journal":{"name":"Leukemia","volume":"199 1","pages":""},"PeriodicalIF":12.8000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41375-025-02544-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Post hoc ergo propter hoc?
We write, somewhat belatedly, to comment on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms [1]. This is a landmark article and global reference on this topic. However, might we take issue on the small but important section heading: Secondary myeloid neoplasms (p. 1710) and especially the sub-section: Myeloid neoplasms post cytotoxic therapy: Introduction of more precise terminology and novel associations with new cytotoxic drug classes. The text goes on to use the term: myeloid neoplasms post cytotoxic therapy (MN-pCT).
期刊介绍：
Title: Leukemia
Journal Overview:
Publishes high-quality, peer-reviewed research
Covers all aspects of research and treatment of leukemia and allied diseases
Includes studies of normal hemopoiesis due to comparative relevance
Topics of Interest:
Oncogenes
Growth factors
Stem cells
Leukemia genomics
Cell cycle
Signal transduction
Molecular targets for therapy
And more
Content Types:
Original research articles
Reviews
Letters
Correspondence
Comments elaborating on significant advances and covering topical issues
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
